Other News To Note
Wednesday, October 5, 2011
X-Body Inc., of Waltham, Mass., inked a partnership with Tanabe Research Laboratories U.S.A. Inc. (TRL), an independent subsidiary of Mitsubishi Tanabe Pharma Corp., of Osaka, Japan. Under terms of the agreement, X-Body will screen its antibody libraries against target cells of therapeutic interest to TRL to identify tissue-specific epitopes and human antibody therapeutic candidates in autoimmune disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.